Physician profile
Manishkumar Patel
NPI 1710143458
$5,022.09
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,301 · 2020: $1,263 · 2021: $434 · 2023: $24.67.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $24.67.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $24.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cardiovascular Systems INC. | $2,495.66 | 2019 | |
| Boston Scientific Corporation | $1,263.26 | 2019-2023 | Wavewriter Alpha Prime 16 |
| Endologix LLC | $215.35 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $215.06 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $197.73 | 2019-2021 | |
| Bard Peripheral Vascular, INC. | $118.11 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $97.43 | 2019-2021 | |
| Abbott Laboratories | $92.33 | 2019-2021 | |
| Amgen INC. | $79.46 | 2019-2021 | |
| Biotronik INC. | $60.30 | 2019 | |
| Acist Medical Systems, INC. | $43.66 | 2020 | |
| Shockwave Medical, INC | $42.35 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $32.99 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $24.97 | 2019-2021 | |
| Chiesi USA, INC. | $23.76 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $19.67 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Manishkumar Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.